Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy.

By C. Cannon, B. Steinberg, S. Murphy, J. Mega, E. Braunwald. Journal of the American College of Cardiology, 2006

777 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery

View Paper: https://www.semanticscholar.org/paper/e6e1320a690e5befd5b0d17df3bb4e4fb85ff075

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Rhian M. Touyz
2. Allan S. Jaffe
3. Marja-Riitta Taskinen
4. I. Graham
5. Hani Jneid
6. E. Braunwald
7. Gerhard Hindricks
8. Stephan Windecker

In Radiology, Nuclear Medicine and Imaging

1. Marja-Riitta Taskinen
2. I. Graham
3. Ulrich Laufs

In Surgery

1. I. Graham
2. Marja-Riitta Taskinen
3. E. Braunwald
4. Alberico L. Catapano
5. Ulrich Laufs
6. Peter Libby

Citations in the corpus

• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. (2016, background): “, through use of higher dose or higher potency agents) can further reduce atherogenic cholesterol particles (primarily LDL-C) and the risk of ASCVD events (186), some residual risk will remain (187).”
• Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis. (2011, background): “6) (1) AE report, (2) DM medication, (3) FPG 126 mg/dL twice”